Oncopeptides AB (publ) (FRA:OND)
0.4510
-0.0370 (-7.58%)
At close: Dec 12, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of €118.3 million as of December 22, 2025. Its market cap has increased by 301.95% in one year.
Market Cap
118.30M
Enterprise Value
118.38M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.45
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 176.17M to 118.30M, a decrease of -32.85%. That is a compound annual growth rate of -4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 118.30M | 304.90% |
| Dec 30, 2024 | 29.22M | -55.05% |
| Dec 29, 2023 | 65.00M | -36.80% |
| Dec 30, 2022 | 102.86M | 66.56% |
| Dec 30, 2021 | 61.75M | -94.61% |
| Dec 30, 2020 | 1.14B | 70.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |